We are live on ! Find out more
MGNX icon

MacroGenics

113 hedge funds and large institutions have $583M invested in MacroGenics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

37% more call options, than puts

Call options by funds: $824K | Put options by funds: $600K

6% more capital invested

Capital invested by funds: $548M → $583M (+$34.7M)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding

Funds holding: 113113 (0)

3.66% less ownership

Funds ownership: 89.48%85.82% (-3.7%)

Holders
113
Holders Change
Holders Change %
0%
% of All Funds
2.82%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
12
Increased
48
Reduced
29
Closed
11
Calls
$824K
Puts
$600K
Net Calls
+$224K
Net Calls Change
+$479K
Name Holding Trade Value Shares
Change
Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$4.1M +$813K +46,914 +27%
SFM
27
Sphera Funds Management
Israel
$3.86M +$2.21M +127,500 +157%
DekaBank Deutsche Girozentrale
28
DekaBank Deutsche Girozentrale
Germany
$3.75M +$346K +20,000 +10%
AG
29
Artal Group
Luxembourg
$3.7M -$1.73M -100,000 -33%
Renaissance Technologies
30
Renaissance Technologies
New York
$3.58M -$579K -33,400 -15%
SIM
31
Spark Investment Management
New York
$3.51M -$812K -46,900 -20%
Jennison Associates
32
Jennison Associates
New York
$3.24M -$255K -14,745 -8%
Charles Schwab
33
Charles Schwab
California
$3.12M +$350K +20,196 +14%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.98M +$25.8K +1,491 +0.9%
DCM
35
DAFNA Capital Management
California
$2.85M +$606K +35,000 +29%
FLAM
36
First Light Asset Management
Minnesota
$2.8M +$1.56M +90,132 +146%
EAM
37
Eventide Asset Management
Massachusetts
$2.72M
Deutsche Bank
38
Deutsche Bank
Germany
$2.23M -$720K -41,559 -26%
AH
39
Aviva Holdings
Bahamas
$2.14M +$2.01M +115,914 New
Principal Financial Group
40
Principal Financial Group
Iowa
$2.11M +$12.1K +700 +0.6%
TAM
41
Tocqueville Asset Management
New York
$1.85M +$433K +25,000 +33%
TCIM
42
TIAA CREF Investment Management
New York
$1.65M +$15.8K +913 +1%
Citadel Advisors
43
Citadel Advisors
Florida
$1.59M +$530K +30,594 +55%
Morgan Stanley
44
Morgan Stanley
New York
$1.37M +$205K +11,822 +19%
Jacobs Levy Equity Management
45
Jacobs Levy Equity Management
New Jersey
$1.36M +$938K +54,161 +279%
Millennium Management
46
Millennium Management
New York
$1.24M -$385K -22,213 -25%
VIA
47
Vident Investment Advisory
Georgia
$1.21M +$34.2K +1,977 +3%
Goldman Sachs
48
Goldman Sachs
New York
$1.13M -$565K -32,635 -35%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.02M
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.01M +$622K +35,920 +191%

MGNX Hedge Fund Activity: Q3 2017 in Review

113 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2017, worth a combined $583M — up 6.3% from $548M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MGNX positions and 11 closed out — a net gain of 1 holder — while 48 added to existing stakes and 29 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $4.05M. The largest seller was Fidelity Investments, cutting an estimated $14.5M.

  • 113 institutional investors held MacroGenics (MGNX) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $583M of MacroGenics stock for Q3 2017, up 6.3% quarter-over-quarter.
  • 12 funds opened new MacroGenics positions in Q3 2017 and 11 closed out, a net change of +1 holder.
  • The largest MacroGenics buyer in Q3 2017 was Pinnacle Associates, an estimated $4.05M added.
  • The largest MacroGenics seller in Q3 2017 was Fidelity Investments, an estimated $14.5M sold.

Based on aggregated 13F filings for Q3 2017.